Costs and Charges, Information on Financial Instruments

Under Global Markets brand, Societe Generale SA, Societe Generale International Limited or Societe Generale Option Europe (hereinafter collectively referred to as “We”, “we” or “us”) is required, pursuant to Article 24.4 of the Directive 2014/65/EU (MiFID II) and to Article 50 of Delegated Regulation 2017/565, to inform its clients (hereinafter “you”) of both the costs and charges of the services we offer and of the products traded with us when we deal as principal, whether we buy or sell, both in primary and secondary markets situations.

You will find below the information related to our ex-ante disclosure pursuant to the said MiFID II regulations by range of products.

Depending on the situation and of the type of financial instrument or product (hereinafter collectively referred as “products”) you may trade with us, the information provided to you may concern the product cost and/or the service cost.

Please note that, when applicable, this disclosure is without prejudice to the service fees that we may agree or have agreed between us for instance for execution service fees.

The grids provide estimates of maximum product costs and charges, based on a previous history of costs on trades in similar financial instruments that may apply to you when trading the said instruments are validunder normal market conditions.

We will periodically review these costs estimates shown in the below grids, as detailed by range of product and make adjustments where necessary.

Please note that the actual costs and charges may vary according to the specific circumstances of each transaction. In any event, our pricing will be determined in accordance with our best execution policy.

This cost information is provided to you for regulatory purposes only. It is not a recommendation, nor an offer to buy or sell a specific product.

Additional information on this cost-and-charge disclosure is available upon request with your usual contact persons at Societe Generale SA or Societe Generale International Limited.

In addition to the cost-and-charge ex-ante disclosure, we are required to provide you with information on financial instruments pursuant to Article 48 of Delegated Regulation 2017/565 in line with your MiFID categorisation either as a retail client, professional client or an eligible counterparty.

Therefore, you will find below some information on financial instruments broken-down by range of products, highlighting the nature and risks of the said instruments without prejudice to any other description you might receive (e.g. marketing brochure, Termsheet, KID,...).